Skip to main content

India Globalization Capital, Inc. (IGC)

NYSEAMERICAN: IGC · IEX Real-Time Price · USD
1.41 -0.06 (-4.08%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap71.96M
Revenue (ttm)391,000
Net Income (ttm)-8.72M
Shares Out47.91M
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume861,901
Open1.45
Previous Close1.47
Day's Range1.41 - 1.46
52-Week Range1.10 - 4.65
Beta4.62
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 15, 2021

About IGC

India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. The company operates through two segments, Infrastructure Business, and Life Sciences. It buys and sells infrastructure commodities, such as steel, wooden doors, marble, and tiles; rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. The company also develops cannabinoid-based products and therapies, such as Hyalolex for the treatment of patients from anxiety, agitation, dementia, depress...

IndustryTrading Companies & Distributors
Founded2005
CEORam Mukunda
Employees50
Stock ExchangeNYSEAMERICAN
Ticker SymbolIGC
Full Company Profile

Financial Performance

In 2020, IGC's revenue was $898,000, a decrease of -77.95% compared to the previous year's $4.07 million. Losses were -$8.81 million, 20.5% more than in 2019.

Financial Statements

News

IGC Announces Results of its 2021 Annual Stockholders Meeting

POTOMAC, Md.--(BUSINESS WIRE)-- #Alzheimers--Voting on all matters as disclosed on the Def Proxy filed with the SEC on Sep 15'21 were passed at IGC's Annual Meeting of Shareholders on Oct 15'21.

1 week ago - Business Wire

IGC Completes its Phase 1 Clinical Trial on Alzheimer's Patients, Reports Safety and Tolerability

POTOMAC, Md.--(BUSINESS WIRE)-- #Alzheimers--IGC Completes its Phase 1 Clinical Trial on Alzheimer's Patients, Reports Safety and Tolerability.

1 month ago - Business Wire

IGC Reports Financial Results for the June 30, 2021, Quarter

BETHESDA, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC announces financial results for quarter ended Jun 30, 2021 & completion of Phase 1 clinical trial of IGC-AD1 to alleviate Alzheimer's symptoms.

2 months ago - Business Wire

An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Prom...

Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment.

Other symbols:SAVA
2 months ago - Benzinga

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

What did the stock market do today? Biotech companies took home gains by the armful, and the Fed reopened debate on tapering spending.

3 months ago - InvestorPlace

Why India Globalization Capital Shares Spiked Today

India Globalization Capital (AMEX:IGC) shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC.  The company was issued a patent...

3 months ago - Benzinga

India Globalization Capital Shares Skyrocket On Receiving Patent For THC Formula To Treat Alzheimer's Disease

India Globalization Capital, Inc. (AMEX: IGC) revealed Thursday that it has obtained a patent from the United States Patent and Trademark Office for the treatment of Alzheimer's disease. The patent (#11...

3 months ago - Benzinga

Highest Volume Penny Stocks to Watch Today? Check These 4 Out

Best high-volume penny stocks for your watchlist right now? Check these 4 out The post Highest Volume Penny Stocks to Watch Today?

Other symbols:EYESPRFX
3 months ago - PennyStocks

IGC Stock: The Huge Cannabis Patent News That Has IGC Flying High

IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis.

3 months ago - InvestorPlace

IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC

POTOMAC, Md.--(BUSINESS WIRE)--IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC

3 months ago - Business Wire

Top Penny Stocks To Buy Now? 10 To Watch As AMC Volatility Continues

Which penny stocks are investors watching with AMC back in focus? The post Top Penny Stocks To Buy Now?

Other symbols:AUUDAYRO
3 months ago - PennyStocks

Pot Stocks in Focus: Cannabis-Based Pharmaceutical Trials

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

3 months ago - Schaeffers Research

IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer's Patients

POTOMAC, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC completed Final Cohort of Phase 1 clinical trial on its THC-based investigational new drug intended to alleviate symptoms of Alzheimer's disease.

3 months ago - Business Wire

IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021.

4 months ago - Business Wire

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 2 of its Phase 1 Tetrahydrocannabinol (“THC”)-Based Investigational New Drug Clinical Trial on Alzheimer's Patients.

4 months ago - Business Wire

India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients

5 months ago - Business Wire

IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC got patent (#10,933,082) x its cannabinoid composition & method x treating pain due to Psoriatic Arthritis, Fibromyalgia, Scleroderma & others.

7 months ago - Business Wire

Update On IGC's Phase 1 Clinical Trial on Alzheimer's Patients

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC completed administering 1st of 3 levels of dosing of IGC-AD1 on its FDA-approved THC-based phase 1 clinical trial on patients with Alzheimer's.

8 months ago - Business Wire

India Globalization Capital Nominates Mr. John E. Lynch to its Board of Directors

BETHESDA, Md.--(BUSINESS WIRE)-- #AD--IGC nominated Mr. Lynch as a Class A independent director for election at the Company's 2020 Annual Meeting of Stockholders, to be held on Jan 11 '21.

10 months ago - Business Wire

IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer's Patients

POTOMAC, MD--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe dementia due...

11 months ago - Business Wire

IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzh...

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2020, which...

11 months ago - Business Wire

IGC's stock rallies again, after rocketing fourfold on record volume in the previous session

Shares of Inc. India Globalization Capital IGC, +300.37% surged 26% in premarket trading Thursday, to extend the fourfold rocket ride in the previous session, as they head for an open at the highest le...

1 year ago - Market Watch

India Globalization Capital More Than Doubles Revenue, Posts Q2 Net Loss of $1.32M

India Globalization Capital, Inc. (NYSE: IGC) reported Wednesday with second-quarter revenue of $1.8 million, up 125% from the same quarter in 2018, when it posted $810,000 in revenue.

1 year ago - Benzinga

India Globalization Capital Subsidiary Secures Hemp Cultivation, Harvesting License In Arizona

Holi Hemp, a subsidiary of India Globalization Capital, Inc. (NYSE: IGC), said Thursday that its application for the cultivation and harvesting of hemp was approved by Arizona’s Department of Agricultur...

2 years ago - Benzinga

A-Rated Stocks to Buy Under $10

These stocks to buy are low-priced, top quality choices for growth. Here's what you need to know about each.

Other symbols:DHTFSIREPHSACH
2 years ago - InvestorPlace